Discgenics, Inc.
SALT LAKE CITY, UT · Founded 2007 · CIK 0001503545 · Biotech · Private
Regenerative therapies for spinal degenerative diseases
discgenics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $870K
- 2 Form D · May 2013
- 161 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 21
- 4 granted · 17 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2010201120122013
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $870,000 | |
| Private capital raised | Form D · SEC | $3,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1821 | NEUROPATHIX, INC. | — | $1.3M |
| 1822 | CUMBERLAND PHARMACEUTICALS, INC. | — | — |
| 1823 | Biohaven Environmental Solutions, LLC | — | $1.4M |
| 1824 | Discgenics, Inc. | — | $870K |
| 1825 | Prairie Pharms, LLC | — | $455K |
| 1826 | Magna Pharmaceuticals, Inc. | — | $1.0M |
| 1827 | CanaQuest Medical Corp. | — | $31K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Mark CohenDirector
- Christopher Duntsch, M.D., Ph.D.Director · Executive Officer
- J. FlanaganDirector · Executive Officer
- Kevin FoleyDirector
- Kevin Foley, M.D.Director · Executive Officer
- Mike MoffatExecutive Officer
- Robert WynalekDirector · Executive Officer
- Greg ZiskindExecutive Officer
Patents
- Human Disc Tissueapplication
- Human Disc Tissuegranted
- Capped Syringes And Methods Of Sealing Sameapplication
- Isolated Discogenic Cells, Methods Of Using, And Methods Of Preparing Same From Mammalian Tissueapplication
- Isolated Discogenic Cells, Methods Of Using, And Methods Of Preparing Same From Mammalian Tissuegranted
- Methods And Systems For Treatment Of Intervertebral Disc By Intradiscal Micro-needle Insertionapplication
- Novel Methods For Production Of Therapeutic Mammalian Cells And Cell Spheres And Compositions Of Sameapplication
- Methods For The Treatment Of Degenerative Disc Diseasegranted
- Devices, Methods, And Compositions Useful In Cryo-preservation, -storage, -transport, And Application Of Therapeutic Mammalian Cellsapplication
- Human Disc Tissuegranted
- Isolated Discogenic Cells, Methods Of Using, And Methods Of Preparing Same From Mammalian Tissueapplication
- Isolated Discogenic Cells And Methods Of Preparing Same From Mammalian Tissueapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.